Non-st-segment Elevation Acute Coronary Syndrome
📧 Sign up to get email alerts when something new happens for Non-st-segment Elevation Acute Coronary Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-11Clinical Trial Update: ANalgesic Efficacy and Safety of MOrphiNe Versus Methoxyflurane in Patients With Acute Myocardial Infarction [Phase 3]
Phase 3 clinical trial comparing analgesic efficacy and safety of Morphine versus Methoxyflurane in acute coronary syndrome, including STEMI…
-
CLINICAL_TRIALS trial_result · 2023-03-22Clinical Trial Update: Prasugrel Or Ticagrelor De-escalation in NSTE-ACS [Phase 3]
Phase 3 clinical trial update on de-escalation of prasugrel or ticagrelor in NSTEMI/NSTE-ACS patients; status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2016-11-09Clinical Trial Update: Different LD of Ticagrelor for Antiplatelet Effect in Patients With Non-ST-segment Elevation ACS Undergoing PCI [Phase 4]
Phase 4 trial evaluating different loading doses of ticagrelor for antiplatelet effect in non-ST-segment elevation acute coronary syndrome p…
-
CLINICAL_TRIALS trial_result · 2015-12-11Clinical Trial Update: COmparison of the Pharmacodynamics and Pharmacokinetics Ticagrelor Versus Clopidogrel in Patients With CKD and NSTE-ACS [Phase 4]
Phase 4 trial comparing pharmacodynamics and pharmacokinetics of ticagrelor versus clopidogrel in patients with chronic kidney disease and n…